FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2791734707> ?p ?o ?g. }

• W2791734707 endingPage "969" @default.
• W2791734707 startingPage "969" @default.
• W2791734707 abstract "The BRAFV600E mutation, which in melanoma is targetable with vemurafenib, is also found in sarcomas and we here evaluate the therapeutic potential in sarcoma cell lines. Methods: Four sarcoma cell lines harboring the BRAFV600E mutation, representing liposarcomas (SA-4 and SW872), Ewing sarcoma (A673) and atypical synovial sarcoma (SW982), were treated with vemurafenib and the effects on cell growth, apoptosis, cell cycle progression and cell signaling were determined. Results: Vemurafenib induced a strong cytostatic effect in SA-4 cells, mainly due to cell cycle arrest, whereas only moderate levels of apoptosis were observed. However, a high dose was required compared to BRAFV600E mutated melanoma cells, and removal of vemurafenib demonstrated that the continuous presence of drug was required for sustained growth inhibition. A limited growth inhibition was observed in the other three cell lines. Protein analyses demonstrated reduced phosphorylation of ERK during treatment with vemurafenib in all the four sarcoma cell lines confirming that the MAPK pathway is active in these cell lines, and that the pathway can be inhibited by vemurafenib, but also that these cells can proliferate despite this. Conclusions: These findings indicate that vemurafenib alone would not be an efficient therapy against BRAFV600E mutated sarcomas. However, further investigations of combination with other drugs are warranted." @default.
• W2791734707 created "2018-03-29" @default.
• W2791734707 creator A5009481797 @default.
• W2791734707 creator A5022804854 @default.
• W2791734707 creator A5056510851 @default.
• W2791734707 creator A5062917876 @default.
• W2791734707 creator A5085893943 @default.
• W2791734707 date "2018-03-23" @default.
• W2791734707 modified "2023-10-11" @default.
• W2791734707 title "Preclinical Evaluation of Vemurafenib as Therapy for BRAFV600E Mutated Sarcomas" @default.
• W2791734707 cites W1539724215 @default.
• W2791734707 cites W1560370693 @default.
• W2791734707 cites W1763457264 @default.
• W2791734707 cites W1846586690 @default.
• W2791734707 cites W1975905403 @default.
• W2791734707 cites W1982393730 @default.
• W2791734707 cites W1982972087 @default.
• W2791734707 cites W1993160539 @default.
• W2791734707 cites W1995033020 @default.
• W2791734707 cites W2004295816 @default.
• W2791734707 cites W2011540855 @default.
• W2791734707 cites W2015448252 @default.
• W2791734707 cites W2017187984 @default.
• W2791734707 cites W2018141092 @default.
• W2791734707 cites W2025130458 @default.
• W2791734707 cites W2052781279 @default.
• W2791734707 cites W2059707627 @default.
• W2791734707 cites W2073039230 @default.
• W2791734707 cites W2074089133 @default.
• W2791734707 cites W2080626878 @default.
• W2791734707 cites W2106543129 @default.
• W2791734707 cites W2107385057 @default.
• W2791734707 cites W2107495112 @default.
• W2791734707 cites W2110682589 @default.
• W2791734707 cites W2123359711 @default.
• W2791734707 cites W2123551753 @default.
• W2791734707 cites W2124662474 @default.
• W2791734707 cites W2144169031 @default.
• W2791734707 cites W2155769700 @default.
• W2791734707 cites W2157539391 @default.
• W2791734707 cites W2160060092 @default.
• W2791734707 cites W2168143310 @default.
• W2791734707 cites W2168711434 @default.
• W2791734707 cites W2175189903 @default.
• W2791734707 cites W2185118998 @default.
• W2791734707 cites W2347652418 @default.
• W2791734707 cites W2419568780 @default.
• W2791734707 cites W2420593137 @default.
• W2791734707 cites W2461628610 @default.
• W2791734707 cites W2570250388 @default.
• W2791734707 cites W2764027545 @default.
• W2791734707 cites W2782531452 @default.
• W2791734707 cites W4232908063 @default.
• W2791734707 doi "https://doi.org/10.3390/ijms19040969" @default.
• W2791734707 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5979358" @default.
• W2791734707 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29570692" @default.
• W2791734707 hasPublicationYear "2018" @default.
• W2791734707 type Work @default.
• W2791734707 sameAs 2791734707 @default.
• W2791734707 citedByCount "11" @default.
• W2791734707 countsByYear W27917347072019 @default.
• W2791734707 countsByYear W27917347072020 @default.
• W2791734707 countsByYear W27917347072021 @default.
• W2791734707 countsByYear W27917347072023 @default.
• W2791734707 crossrefType "journal-article" @default.
• W2791734707 hasAuthorship W2791734707A5009481797 @default.
• W2791734707 hasAuthorship W2791734707A5022804854 @default.
• W2791734707 hasAuthorship W2791734707A5056510851 @default.
• W2791734707 hasAuthorship W2791734707A5062917876 @default.
• W2791734707 hasAuthorship W2791734707A5085893943 @default.
• W2791734707 hasBestOaLocation W27917347071 @default.
• W2791734707 hasConcept C121608353 @default.
• W2791734707 hasConcept C126322002 @default.
• W2791734707 hasConcept C142724271 @default.
• W2791734707 hasConcept C184235292 @default.
• W2791734707 hasConcept C190283241 @default.
• W2791734707 hasConcept C2776131300 @default.
• W2791734707 hasConcept C2776910622 @default.
• W2791734707 hasConcept C2777658100 @default.
• W2791734707 hasConcept C2778256501 @default.
• W2791734707 hasConcept C29537977 @default.
• W2791734707 hasConcept C2994587330 @default.
• W2791734707 hasConcept C502942594 @default.
• W2791734707 hasConcept C54355233 @default.
• W2791734707 hasConcept C55493867 @default.
• W2791734707 hasConcept C57074206 @default.
• W2791734707 hasConcept C62112901 @default.
• W2791734707 hasConcept C71924100 @default.
• W2791734707 hasConcept C81885089 @default.
• W2791734707 hasConcept C86803240 @default.
• W2791734707 hasConcept C95444343 @default.
• W2791734707 hasConceptScore W2791734707C121608353 @default.
• W2791734707 hasConceptScore W2791734707C126322002 @default.
• W2791734707 hasConceptScore W2791734707C142724271 @default.
• W2791734707 hasConceptScore W2791734707C184235292 @default.
• W2791734707 hasConceptScore W2791734707C190283241 @default.
• W2791734707 hasConceptScore W2791734707C2776131300 @default.
• W2791734707 hasConceptScore W2791734707C2776910622 @default.

• next